Belite Bio Cash Flow Statement (2021-2026) | BLTE

Cash Flow Statement Dec2021 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -2.39B-2.40B-0.01B-6.89B-6.81B-0.01B-0.01B-7.87B-9.49B-8.67B-10.10B-0.01B-16.32B-21.69B-25.32B-0.03B
Depreciation and Depletion (Quarter) 0.00B0.00B
Share-based Compensation (Quarter) 0.00B0.00B-0.00B0.01B
Cash from Operations (Quarter) -0.00B-0.01B
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter) 0.00B0.00B
Depreciation & Amortization (CF) (Quarter) 0.00B0.00B
Change in Working Capital
Change in Account Payables (Quarter) -0.00B-0.00B
Change in Accured Expenses (Quarter) 0.00B0.00B
Investing Activities
Capital Expenditures (Quarter) 0.00B
Change in Acquisitions & Divestments (Quarter) 0.04B0.05B
Cash from Investing Activities (Quarter) -0.03B-0.30B
Financing Activities
Other financing activities (Quarter) 0.02B0.04B0.00B
Change in Capital Stock
Shares Issued (Quarter) 0.00B0.00B0.00B0.01B0.00B
Net Equity Issued and Repurchased (Quarter) 0.01B0.05B
Misc.
Cash from Financing Activities (Quarter) 0.04B0.51B
Exchange Rate Effect (Quarter) -0.00B-0.00B
Change in Cash (Quarter) 0.01B0.20B
Free Cash Flow (Quarter) -0.00B-0.01B
Net Cash Flow (Quarter) 0.01B0.20B